SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers:
SEC Accession No. 0001628280-24-007660
Filing Date
2024-02-28
Accepted
2024-02-28 17:13:50
Documents
12
Effectiveness Date
2024-02-28

Document Format Files

Seq Description Document Type Size
1 S-3ASR editass-3asrfebruary2024.htm S-3ASR 499253
2 EX-FILING FEES exhibit107-sx3asr.htm EX-FILING FEES 66619
3 EX-1.2 exhibit12-sx3asr.htm EX-1.2 278851
4 EX-4.4 exhibit44-sx3asr.htm EX-4.4 427371
5 EX-4.5 exhibit45-sx3asr.htm EX-4.5 450479
6 EX-4.6 exhibit46-sx3asr.htm EX-4.6 49537
7 EX-4.7 exhibit47-sx3asr.htm EX-4.7 50093
8 EX-5.1 exhibit51-sx3asr.htm EX-5.1 49915
9 EX-23.1 exhibit231-sx3asr.htm EX-23.1 2610
10 editaslogoa.jpg GRAPHIC 20410
11 logo1a.jpg GRAPHIC 36002
12 logo2a.jpg GRAPHIC 207543
  Complete submission text file 0001628280-24-007660.txt   2236339
Mailing Address 11 HURLEY ST. CAMBRIDGE MA 02141
Business Address 11 HURLEY ST. CAMBRIDGE MA 02141 617-401-9000
Editas Medicine, Inc. (Filer) CIK: 0001650664 (see all company filings)

IRS No.: 464097528 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3ASR | Act: 33 | File No.: 333-277471 | Film No.: 24696835
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)